Print Page  |  Close Window

SEC Filings

Form 6-K
TEVA PHARMACEUTICAL INDUSTRIES LTD filed this Form 6-K on 08/03/2017
Document Outline
Entire Document (7336.5 KB)
Subdocument 1 - 6-K - FORM 6-K
Page 1 - UNITED STATES
Page 2 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 3 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 4 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 5 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 6 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 7 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 8 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 9 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 10 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 11 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 12 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 13 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 14 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 15 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 16 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 17 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 18 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 19 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 20 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 21 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 22 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 23 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 24 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 25 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 26 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 27 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 28 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 29 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 30 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 31 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 32 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 33 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 34 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 35 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 36 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 37 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 38 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 39 - TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Page 40 - OPERATING AND FINANCIAL REVIEW AND PROSPECTS
Page 41 - Introduction
Page 42 - Otsuka Out-License
Page 43 - Segment Information
Page 44 - United States Generic Medicines Revenues
Page 45 - Launches
Page 46 - Europe Generic Medicines Revenues
Page 47 - ROW Generic Medicines Revenues
Page 48 - Generic Medicines S M Expenses
Page 49 - Specialty Medicines Revenues
Page 50 - Azilect
Page 51 - ProAir
Page 52 - Specialty Medicines R D Expenses
Page 53 - Teva Consolidated Results
Page 54 - Impairments, Restructuring and Others
Page 55 - Financial Expenses - Net
Page 56 - Comparison of Six Months Ended June 30, 2017 to Six Months Ended June 30, 2016
Page 57 - Segment Information
Page 58 - Europe Generic Medicines Revenues
Page 59 - Specialty Medicines Revenues
Page 60 - QVAR
Page 61 - Gross Profit
Page 62 - Financial Expenses-Net
Page 63 - Impact of Currency Fluctuations on Results of Operations
Page 64 - 2017 Debt Balance and Movements
Page 65 - Commitments
Page 66 - Investors should consider non-GAAP financial measures in addition to, and not as replacements for, o
Page 67 - N/A
Page 68 - Investors should consider non-GAAP financial measures in addition to, and not as replacements for, o
Page 69 - N/A
Page 70 - Non-GAAP Tax Rate
Page 71 - SIGNATURES
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE (What's this?)
XBRL Viewer